Ameriprise
BJCT

Ameriprise’s BIOJECT MEDICAL TECHS INC BJCT Stock Holding History

Ameriprise’s Portfolio BJCT Stock Details BJCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-6,100
Closed -$1K – 5305
2014
Q3 		$1K Hold
6,100
– – ﹤0.01% 5701
2014
Q2 		$1K Hold
6,100
– – ﹤0.01% 5496
2014
Q1 		$1K Hold
6,100
– – ﹤0.01% 5263
2013
Q4 		$0 Hold
6,100
– – ﹤0.01% 5878
2013
Q3 		$0 Hold
6,100
– – ﹤0.01% 5868
2013
Q2 		$1K Buy
+6,100
New +$1K ﹤0.01% 5472

Other funds holding BJCT

FBA
Front Barnett Associates Chicago, Illinois $833M AUM 23.51% 1-Year Est. Return

Ameriprise's BJCT Position: Q4 2014 in Review

Ameriprise sold out of BIOJECT MEDICAL TECHS INC (BJCT) in Q4 2014, closing a stake of 6,100 shares — an estimated $1K sold.

Ameriprise first reported a position in BJCT in Q2 2013 and held it in 6 quarters. The position peaked at $1K in Q3 2014. 1 fund tracked by Wall St. Rank holds BJCT as of Q4 2014.

  • Ameriprise reported no remaining BIOJECT MEDICAL TECHS INC position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 6,100 BIOJECT MEDICAL TECHS INC shares in Q4 2014, an estimated $1K.
  • Ameriprise first reported a position in BIOJECT MEDICAL TECHS INC in Q2 2013 and held it in 6 quarters.
  • Ameriprise's BIOJECT MEDICAL TECHS INC position peaked at $1K in Q3 2014.
  • 1 fund tracked by Wall St. Rank held BIOJECT MEDICAL TECHS INC as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.